Participated · Series A · Mar 2023

Vitraya Technologies builds an AI-based platform that enables automated, in-the-moment payouts and claim settlements between hospitals, healthcare facilities, and insurers. Its technology underwrites and makes claims decisions in less than one-millionth of a second and automates fraud checks to settle claims in real time within microseconds. The platform secures hospital, patient, and policy data in discrete blocks to enable safe communication among parties. Customers include Indian health insurers such as STAR, Niva Bupa, and CARE Health Insurance. The company says its system reduces operational costs and improves the patient experience, and can be used by small, medium, and large hospitals. Vitraya intends to use the new funding to scale current products and technologies, hire personnel, and pursue international business development. Founded in 2019 by Mrinal Sinha and based in Mohali, the company previously raised $4.1 million in a pre-Series A in January.

Participated · Series A · Nov 2022

LUMIQ operates LiteCone, a platform that deploys AI agents which read files, apply an institution's guidelines, and make end-to-end regulated decisions with full reasoning and audit trails. The company reports agents are live in production at leading banks, insurers, and capital markets firms across India, the US, and Southeast Asia and processes millions of decisions annually. LUMIQ cites a leading life-insurer deployment where its LEO agent decides 75–80% of underwriting cases with zero human touch, reduced policy issuance cost by roughly 25%, and cut turnaround from days to under eight minutes. The firm employs over 350 AI and data specialists and has offices in New Jersey, Singapore, and Delhi NCR. LUMIQ plans to deepen decisioning capabilities, expand the range of roles its agents handle, and embed LiteCone via partnerships with cloud hyperscalers, AI labs, and core banking and insurance platforms.

Participated · Series A · May 2022

Twixor offers a low-code/no-code platform (Twixor AIM) that surfaces business services on customers' channel of choice—WhatsApp, Facebook Messenger, PWA over SMS or web, QR scans, or voice—using conversational AI and NLP. Its platform includes a BPM engine, AI-driven bots, and PWA capsules to enable end-to-end digital process automation and hyper-personalized engagement. The company positions itself as an "Actionable Intelligence Platform" to accelerate enterprise digital transformation and improve last-mile communications. Twixor focuses on connecting customer interactions to business processes and enabling fulfillment workflows initiated by customers. The company intends to use the new funding to drive continued product innovation, strengthen strategic partnerships, expand globally, and hire talent.

Led · Series A · Sep 2021

Aerchain offers a "Spend Operating System" that uses a multi-agent AI architecture trained on each customer’s data to manage the full intake-to-pay procurement lifecycle. Its platform includes conversational intake and SOW generation, vendor discovery and management, RFQ and auction automation, autonomous negotiation, techno-commercial evaluation, contract management, invoice processing, and payment tracking. Aerchain says its Spend Orchestration layer automates roughly 80% of operational procurement work and has reduced task completion times from days to hours. The company reports being trusted by over 50 global enterprise customers across more than 30 countries and managing $45 billion in spend, while cutting procurement cycle times by over 50%. Founded in 2021 and headquartered in Bengaluru, Aerchain plans to use its Series A proceeds to accelerate global expansion and deepen its AI capabilities.

Participated · Series A · Mar 2021

Founded in 2018 and based in Bengaluru, 4baseCare develops genomics-driven, AI-enabled clinical intelligence for precision oncology through its platform OncoTwin. The company combines genomic testing with AI-powered clinical context to improve personalized cancer treatment and to address underrepresentation of non‑Caucasian populations in genomic datasets. 4baseCare is expanding a hospital-linked genomics laboratory network across India, the Middle East, Southeast Asia, Latin America and Central Asia. Financially, it has completed a Series A of Rs 50 crore led by Yali Capital with participation from Infosys, and an extended Series B totaling Rs 128 crore after the recent Rs 38-crore infusion led by GrowX Ventures. The fresh capital is earmarked for geographic expansion and scaling its OncoTwin platform.